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HPS Gene Mutations in Hermansky-Pudlak Syndrome
To the Editor:
We recently reported a series of mutations of the HPS
gene in non–Puerto Rican patients with Hermansky-
Pudlak syndrome (MIM 203300) (Oh et al. 1998). One
of these mutations was designated incorrectly in some
places in the article; a frameshift in codon Q397 was
incorrectly designated “E397” in the text (this mutation
is now designated “c1189delC,” in the new nomencla-
ture; Antonarakis 1998). In addition, subsequent to pub-
lication we determined that patient 20 is homozygous
for a novel frameshift due to a single-base deletion in
codon G96, designated “c288delT,” with the first-cousin
parents both being heterozygous for this mutation. Thus,
HPS gene mutations have now been identified in all pa-
tients and families who show apparent linkage to 10q23.
With our original description of the gene (Oh et al. 1996)
and the recent report of Shotelersuk et al. (1998), this
brings the number of reported HPS gene mutations to
11 and further underscores the lack of missense muta-
tions identified in patients with this disorder.
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A Novel 22q11.2 Microdeletion in DiGeorge
Syndrome
To the Editor:
DiGeorge syndrome (DGS; MIM 188400) is a multiple-
malformation syndrome characterized by aplasia or hy-
poplasia of the thymus; immunodeficiency, aplasia, or
hypoplasia of the parathyroid glands; conotruncal car-
diac defects; and typical facial anomalies(DiGeorge
1965; Conley et al. 1979). Despite causal heterogeneity
(Lammer and Opitz 1986), ∼90% of patients with DGS
have hemizygosity of an ∼1.5–3-Mb region within
22q11.2 (Driscoll et al. 1990; Scambler et al. 1991; Dris-
coll et al. 1992a). Because of phenotypic overlap, the
same deletion was demonstrated in the majority of pa-
tients with velo-cardio-facial syndrome (VCFS; MIM
192430) (Driscoll et al. 1992b; Carlson et al. 1997b),
which was initially characterized by hypernasal speech
caused by cleft palate, cardiac anomalies, learning dis-
abilities, and typical facial appearance (Shprintzen et al.
1978, 1981). In addition, 22q11.2 deletions were ob-
served in cases fitting within the spectrum of Cayler syn-
drome (MIM 125520) (Giannotti et al. 1994), Takao
conotruncal anomaly face syndrome (contained in MIM
188400) (Burn et al. 1993), Noonan syndrome (MIM
163915) (Wilson et al. 1993), Kousseff syndrome (MIM
245210) (Nickel et al. 1994), andOpitz GBBB syndrome
(MIM 145410) (McDonald-McGinn et al. 1995).Mean-
while, it became evident that deletion 22q11.2 is asso-
ciated with a phenotypic spectrum that may present as
one of the aforementioned syndromes or any condition
in between them that has considerable inter- and intra-
familial variability (De Silva et al. 1995; Leana-Cox et
al. 1996; Devriendt et al. 1997; Ryan et al. 1997). There-
fore, 22q11.2 microdeletion is one of the most common
genetic defects, with an estimated incidence of 11 in
5,000 (Wilson et al. 1994; Tezenas Du Montcel et al.
1996). According to Carlson et al. (1997b), 90% of
patients with deletions have a common 3-Mb deletion,
8.5% have a proximal 1.5-Mb deletion, and 3% have
unique nested proximal deletions, which may define a
proximal shortest region of overlap within the com-
monly deleted 3-Mb region. Because of two patientswith
small deletions in the distal part of the 3-Mb deletion,
a distal shortest region of overlap within the deleted
region may also be defined (Kurahashi et al. 1997;
O’Donnell et al. 1997). However, there is no obvious
correlation between the site or size of the deletion and
the severity of the clinical manifestations, and position
effects have been taken into consideration (Carlson et
al. 1997b; Kurahashi et al. 1997; O’Donnell et al. 1997).
We describe here a novel 22q11.2 microdeletion in a
family with mild to severe phenotype. This deletion is
adjacent to but does not overlap with the known dele-
tions. Nevertheless, it shows similar clinical character-
istics and may therefore give a clue to the mechanisms
and genes involved in phenotype determination in
22q11.2 deletions.
Patient III:3 was primarily investigated in the context
of a study of incidence and significance of 22q11.2 hemi-
zygosity in patients with interrupted aortic arch (Rauch
et al. 1998b). Within that study, she was the only patient
with symptoms of the DGS/VCFS spectrum who did not
have the 22q11.2 deletion and, therefore, prompted fur-
ther analysis. Phenotype assessment of the patient, her
parents, and her sibs was performed before molecular
studies and included dysmorphologic analysis of lym-
phocyte subpopulations by flow cytometry on an Or-
thoscan, by means of fluorochrome-labeled antibodies
against CD3, CD4, CD8, and CD19; and surface im-
munoglobulin (according to Becton-Dickinson). Diph-
theria toxoid and tetanus toxoid were measured after
vaccination, by means of a commercially available en-
zyme-linked immunosorbent assay (ELISA) (ABICAP;
Abion). Parathyroid hormone levels were determined by
chemoluminescence-ELISA (Nichols) of the patient’s
sera. Cardiac status was established by echocardio-
graphy and angiography in the patient and by echocardi-
ography only in the patient’s parents and sibs. Flexible
transnasal pharyngoscopy was performed in the pa-
tient’s sister and mother, to exclude velopharyngeal
insufficiency.
